Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 29: 2049-2053, 1983;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, J. T.
Right arrow Articles by Knight, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, J. T.
Right arrow Articles by Knight, J. A.

Clinical Chemistry, Vol 29, 2049-2053, Copyright © 1983 by American Association for Clinical Chemistry

Interference with carcinoembryonic antigen radioimmunoassays by glycosaminoglycans, and their removal

JT Wu, E Mau and JA Knight

Using the reagents from the CEA-Roche kit, we found that solutions containing only glycosaminoglycans (GAG) yielded false concentrations of carcinoembryonic antigen (CEA), and mixtures of CEA and GAG produced falsely high values. On the other hand, solutions of GAG yielded no additional CEA concentration when reagents from the Abbott CEA kit were used; rather, the CEA result was decreased with the Abbott kit for a CEA solution also containing GAG. These effects of GAG were not ascribable to contamination, because neither gel filtration nor ion- exchange column chromatography separated the false Roche CEA content related to GAG from their peaks of uronic acid or from their anticoagulant activity. In addition, an enzyme specific for GAG eliminated these GAG-derived false concentrations. Both the positive and negative effects are correlated with concentrations of GAG. We found that the concentration of GAG could be decreased in a solution containing plasma proteins by either heating (70 degrees C, 15 min) or treating with perchloric acid (0.6 mol/L). The former is superior because essentially all GAG added to a solution containing plasma proteins were removed by heat, whereas as much as 25% to 80% of the GAG still remained after acid treatment. The effect of GAG was also completely eliminated by treating the specimens with chondroitinase ABC lyase (EC 4.2.2.4).




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Association for Clinical Chemistry.